Acadian Asset Management LLC Aldeyra Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

$34.5 Billion
Q4 2024

A detailed history of Acadian Asset Management LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,279 shares of ALDX stock, worth $8,556. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,279

Previous 254,314 99.5%

Holding current value

$8,556

Previous $1.37 Million 99.56%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$4.21 - $5.9 $1.07 Million - $1.49 Million	-253,035 Reduced 99.5%	1,279 $6,000
Q3 2024 Nov 12, 2024	SELL	$3.19 - $6.32 $611,114 - $1.21 Million	-191,572 Reduced 42.96%	254,314 $1.37 Million
Q2 2024 Aug 06, 2024	SELL	$3.25 - $4.72 $21,329 - $30,977	-6,563 Reduced 1.45%	445,886 $1.48 Million
Q1 2024 May 10, 2024	BUY	$2.77 - $4.22 $645,878 - $983,973	233,169 Added 106.33%	452,449 $1.48 Million
Q4 2023 Feb 13, 2024	BUY	$1.47 - $6.06 $322,341 - $1.33 Million	219,280 New	219,280 $768,000
Q1 2021 May 11, 2021	SELL	$6.53 - $14.42 $221,928 - $490,078	-33,986 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$6.31 - $8.13 $214,451 - $276,306	33,986 New	33,986 $233,000
Q3 2020 Nov 09, 2020	SELL	$4.0 - $7.53 $637,780 - $1.2 Million	-159,445 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.97 - $5.05 $248,903 - $638,052	126,347 Added 381.74%	159,445 $665,000
Q1 2020 May 11, 2020	BUY	$1.62 - $6.4 $45,487 - $179,705	28,079 Added 559.45%	33,098 $82,000
Q4 2019 Feb 06, 2020	BUY	$4.73 - $7.98 $23,739 - $40,051	5,019 New	5,019 $29,000
Q2 2019 Aug 08, 2019	SELL	$6.0 - $9.0 $96,264 - $144,396	-16,044 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$7.14 - $9.85 $114,554 - $158,033	16,044 New	16,044 $145,000
Q3 2018 Oct 30, 2018	SELL	$6.8 - $14.35 $94,064 - $198,503	-13,833 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$6.95 - $9.18 $41,109 - $54,299	5,915 Added 74.7%	13,833 $110,000
Q1 2018 Apr 12, 2018	BUY	$6.55 - $8.9 $15,615 - $21,217	2,384 Added 43.08%	7,918 $59,000
Q4 2017 Jan 18, 2018	BUY	$5.7 - $7.75 $31,543 - $42,888	5,534	5,534 $38,000

Others Institutions Holding ALDX

# of Institutions

127

Shares Held

37.6M

Call Options Held

757K

Put Options Held

539K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $390M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Aldeyra Therapeutics, Inc. Transaction History